ATE473448T1 - Verfahren zur diagnose von herz-kreislauf- krankheiten - Google Patents
Verfahren zur diagnose von herz-kreislauf- krankheitenInfo
- Publication number
- ATE473448T1 ATE473448T1 AT07718389T AT07718389T ATE473448T1 AT E473448 T1 ATE473448 T1 AT E473448T1 AT 07718389 T AT07718389 T AT 07718389T AT 07718389 T AT07718389 T AT 07718389T AT E473448 T1 ATE473448 T1 AT E473448T1
- Authority
- AT
- Austria
- Prior art keywords
- amount
- precursor
- fragments
- sample
- cardiovascular diseases
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4742—Keratin; Cytokeratin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/545—IL-1
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT6942006 | 2006-04-24 | ||
PCT/AT2007/000173 WO2007121495A2 (en) | 2006-04-24 | 2007-04-16 | Method for diagnosing cardiovascular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE473448T1 true ATE473448T1 (de) | 2010-07-15 |
Family
ID=38171226
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07718389T ATE473448T1 (de) | 2006-04-24 | 2007-04-16 | Verfahren zur diagnose von herz-kreislauf- krankheiten |
Country Status (7)
Country | Link |
---|---|
US (1) | US8129135B2 (de) |
EP (1) | EP2010921B1 (de) |
JP (1) | JP2009534672A (de) |
AT (1) | ATE473448T1 (de) |
DE (1) | DE602007007595D1 (de) |
ES (1) | ES2346483T3 (de) |
WO (1) | WO2007121495A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2937339B1 (fr) * | 2008-10-21 | 2013-02-15 | Univ Bourgogne | Procede de detection de la maladie atheromateuse. |
GB0911569D0 (en) | 2009-07-03 | 2009-08-12 | Ulive Entpr Ltd | Method for the detection of organ or tissue injury |
NZ624609A (en) * | 2009-08-28 | 2015-12-24 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
CN110089997A (zh) * | 2018-01-31 | 2019-08-06 | 上海交通大学 | 基于体表自发荧光左右对称性和强度判断心肌梗死和心力衰竭及愈后程度的方法及其应用 |
CN110090001A (zh) * | 2018-01-31 | 2019-08-06 | 上海交通大学 | 自发荧光在判断心脑血管病中的应用 |
CN110089999A (zh) * | 2018-01-31 | 2019-08-06 | 上海交通大学 | 基于角蛋白片段和角蛋白水平及左右对称性的检测判断心脑血管疾病的应用和方法 |
CN110095440A (zh) * | 2018-01-31 | 2019-08-06 | 上海交通大学 | 基于体表自发荧光左右对称性和强度判断脑卒中发生及愈后程度的方法及其应用 |
CN110132906A (zh) * | 2018-02-02 | 2019-08-16 | 上海交通大学 | 基于指甲自发荧光左右对称性和强度判断心肌梗死和心力衰竭及愈后程度的方法及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2321351T3 (es) * | 1997-09-30 | 2009-06-04 | Peviva Ab | Compuesto relacionados con apoptosis y su uso. |
EP1666881B1 (de) * | 2001-05-04 | 2010-02-17 | Biosite Incorporated | Diagnostische Marker der akuten koronaren Syndrome und ihre Verwendungen |
WO2008049422A2 (de) * | 2006-10-26 | 2008-05-02 | Brahms Aktiengesellschaft | Risikostratifizierung des akuten koronarsyndroms mittels fragmenten / teilpeptiden des provasopressins, insbesondere copeptin oder neurophysin ii |
-
2007
- 2007-04-16 AT AT07718389T patent/ATE473448T1/de active
- 2007-04-16 WO PCT/AT2007/000173 patent/WO2007121495A2/en active Application Filing
- 2007-04-16 EP EP07718389A patent/EP2010921B1/de not_active Not-in-force
- 2007-04-16 JP JP2009506856A patent/JP2009534672A/ja not_active Ceased
- 2007-04-16 DE DE602007007595T patent/DE602007007595D1/de active Active
- 2007-04-16 US US12/298,209 patent/US8129135B2/en not_active Expired - Fee Related
- 2007-04-16 ES ES07718389T patent/ES2346483T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
EP2010921A2 (de) | 2009-01-07 |
DE602007007595D1 (en) | 2010-08-19 |
EP2010921B1 (de) | 2010-07-07 |
JP2009534672A (ja) | 2009-09-24 |
ES2346483T3 (es) | 2010-10-15 |
WO2007121495A2 (en) | 2007-11-01 |
WO2007121495A3 (en) | 2008-02-21 |
US8129135B2 (en) | 2012-03-06 |
US20090098104A1 (en) | 2009-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE473448T1 (de) | Verfahren zur diagnose von herz-kreislauf- krankheiten | |
WO2005048823A3 (en) | Modeling of systemic inflammatory response to infection | |
ATE514950T1 (de) | Verfahren zur untersuchung von sepsis bei menschen | |
EP1718334A4 (de) | Verfahren zur diagnose und behandlung von präeklampsie oder eklampsie | |
WO2008015254A3 (en) | Means and methods for assessing the risk of cardiac interventions based on gdf-15 | |
ATE452343T1 (de) | Verbesserte vitamin-d-messung | |
CY1107859T1 (el) | Μεθοδος για διαγνωση πολλαπλης σκληρυνσης | |
ATE440151T1 (de) | Verfahren zur beurteilung eines krankheitzustandes mittels nachweis von partikel- und nicht partikelgebundenen nukleinsäuren in blutplasma und -serum | |
ATE482398T1 (de) | Verfahren zur stratifizierung von herzinsuffizienz | |
WO2007090126A3 (en) | Compositions and methods for detecting and quantifying toxic substances in disease states | |
WO2005042761A3 (en) | Biomarkers for amyotrophic lateral sclerosis | |
WO2006036744A3 (en) | Methods for a global assay of coagulation and fibrinolysis | |
WO2006092729A3 (en) | Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals | |
NO20050186L (no) | Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser | |
HRP20191862T1 (hr) | Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina | |
DE502006008028D1 (de) | Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen | |
WO2005098433A3 (en) | Diagnostic assays for alzheimer’s disease | |
ATE472611T1 (de) | Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression | |
ATE524561T1 (de) | Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken | |
ATE478335T1 (de) | Verfahren in echtzeit zur erkennung von akuten entzündungszuständen | |
DE502006004301D1 (de) | Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum | |
ATE557277T1 (de) | Verfahren zur diagnose von endometriose mittels tfpi-2 protein | |
WO2009016734A1 (ja) | 軽度認知機能障害の検定方法 | |
WO2006002930A3 (en) | FcϜRIIa POLYMORPHISM AND ITS USE IN DIAGNOSIS | |
ATE355389T1 (de) | Verfahren zur diagnose von schizophrenie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 2010921 Country of ref document: EP |